Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.90
+0.54 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
10.97
+0.07 (0.64%)
After-hours: Jun 26, 2026, 7:31 PM EDT
Kura Oncology Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Kura Oncology stock have an average target of 27.3, with a low estimate of 15 and a high estimate of 40. The average target predicts an increase of 150.46% from the current stock price of 10.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kura Oncology stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 12 | 12 | 12 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 14 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $25 | Buy | Maintains | $25 | +129.36% | Jun 23, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $28 | Buy | Maintains | $28 | +156.88% | Jun 15, 2026 |
| Wedbush | Wedbush | Buy Reiterates $36 | Buy | Reiterates | $36 | +230.28% | Jun 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $28 | Buy | Maintains | $28 | +156.88% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +266.97% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
95.04M
from 67.48M
Increased by 40.84%
Revenue Next Year
214.56M
from 95.04M
Increased by 125.75%
EPS This Year
-3.46
from -3.18
EPS Next Year
-2.60
from -3.46
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 131.2M | 473.0M | |
| Avg | 95.0M | 214.6M | |
| Low | 72.6M | 129.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 94.4% | 397.7% | |
| Avg | 40.8% | 125.8% | |
| Low | 7.6% | 36.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.78 | -2.08 | |
| Avg | -3.46 | -2.60 | |
| Low | -3.72 | -3.48 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.